FDA Approves Glaxo Swine Flu Vaccine

A swine flu vaccine made by British drug maker GlaxoSmithKline is now approved for use in the United States.

In a news release, the company said that the U.S. Food and Drug Administration had approved the unadjuvanted influenza A (H1N1) pandemic vaccine, Agence France Presse reported.

"The United States Department of Health and Human Services has placed an order to fill 7.6 million doses of unadjuvanted H1N1 pandemic vaccine from GSK, which will contribute to the approximately 250 million doses secured by the U.S. government," the company said.

The makeup of the GSK swine flu vaccine approved for use in the United States is different than that of Pandermix, the company's drug recently approved in Europe to treat swine flu, AFP reported.

More on This

• Man dies of bird flu in southwest China: Xinhua
• Bird flu researchers suspend study of mutations
• More labs close to deadly bird flu mutations
• Bird flu virus doesn't jump between humans: China

Tags

• Influenza
• Political Issues

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Do you really want to post anonymously?

Are You a Member? Log InConnect your comment to your member profile. It only takes a second! Not a Member? Join Now!You'lll be automatically notified when someone else comments on your post.

Tell us what you think Write your comment here *

Leave this field blank

Receive email notifications of new comments Email Addresss

Sign me up for EmpowHER's FREE Newsletter!

Type in the characters above *

By hitting submit, you agree to EmpowHER's terms of service and privacy policy